PFE Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo
PFE Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
PFE - Pfizer announces positive topline phase 3 results for litfulo in patients with nonsegmental vitiligo - Pfizer announces positive topli
PFE - Pfizer announces positive topline phase 3 results for litfulo in patients with nonsegmental vitiligo - Pfizer announces positive topline phase 3 results for litfulo in patients with nonsegmental vitiligo - Litfulo phase 3 studies meet Co-primary endpoints at week 52 in vitiligo - Litfulo safety profile in nsv con